Behavioral Weight and Symptom Management for Breast Cancer Survivors and Partners
乳腺癌幸存者和伴侣的行为体重和症状管理
基本信息
- 批准号:9404518
- 负责人:
- 金额:$ 0.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-01 至 2018-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdjuvantAftercareArthritisBehaviorBehavioralBiologicalBiological MarkersBody Weight decreasedBreast Cancer survivorCancer InterventionCancer SurvivorCardiovascular DiseasesCaregiversCessation of lifeChronic DiseaseComorbidityCoping BehaviorCouplesDataDiabetes MellitusDiagnosisDietDisease OutcomeDisease ProgressionDistressEatingEating BehaviorFatigueFocus GroupsGeneral PopulationGoldGrowthGuidelinesHealthHealth BenefitHealth behaviorHealth behavior changeHealthy EatingHeart RateIL8 geneImmunityImpairmentIndividualInflammatoryInsulinInterleukin-6InterventionLinkMaintenanceMeasuresMedicalModelingMonitorMorbidity - disease rateObesityOutcomeOutcome StudyOverweightPainParticipantPhasePhysical activityPopulationProceduresProcessProtocols documentationPsychological FactorsPublic HealthQuality of lifeRecurrenceResearchSurvivorsSymptomsTNF geneTestingTreatment EfficacyWeightWeight GainWeight maintenance regimenWomanWorkadiponectinarmbasebehavior changecancer diagnosiscancer recurrencecancer riskcardiovascular disorder riskcaregivingcommon symptomcommunecopingcytokinedisorder riskhigh riskimmune functionimprovedimproved functioninginnovationmalignant breast neoplasmmortalitynovelphase 1 studyphase 2 studyphysical conditioningphysical symptompilot trialprimary caregiverpsychologicpsychological distresspsychological symptompublic health relevancesymptom managementtherapy developmenttumor initiationweight loss interventionweight maintenance
项目摘要
DESCRIPTION (provided by applicant): Breast cancer is the most commonly diagnosed cancer in women, and estimates suggest that one third of breast cancer survivors are obese. The partners of obese breast cancer survivors are also likely to be overweight or obese. Being overweight or obese is associated with increased risk of disease progression, recurrence, and death for breast cancer survivors as well as poor health outcomes for partners (e.g., cardiovascular disease, impaired immune functioning, mortality). For both survivors and partners, pain, fatigue, and psychological distress are common. These symptoms can serve as barriers to healthy eating and physical activity, two behaviors necessary for weight loss and maintenance. Research suggests a significant and positive relationship between health behaviors within couples. Dyadic health behavior change interventions have demonstrated efficacy and may even be more efficacious than interventions targeting only one individual. Behavioral weight loss interventions for cancer survivors have not typically involved the partner. Further, behavioral weight loss interventions rarely address physical and psychological symptoms that are related to poor eating and inactivity. We propose to develop and test the feasibility, acceptability, and initial efficacy of a novel dyadic behavioral weight and symptom management intervention for obese breast cancer survivors and their partners. The proposed project consists of two phases. Phase I will include intervention development and refinement. Intervention development will be guided by the research team's prior work, the interdependence model of communal coping and behavior change, and information obtained from dyads participating in focus groups (N=3 focus groups, N=15 dyads). The intervention protocol will then be tested with 5 dyads to assist with refinement of intervention content. During phase II, the feasibility, acceptability and initial efficacy of the intervention will be examined. Obese brest cancer survivors in the first year following adjuvant treatment and their overweight or obese partners (N=20 dyads) will receive 6 weekly and 6 biweekly sessions for a total of 12 sessions spaced across approximately 5 months. The intervention will be provided in a couples-based format where each dyad will meet separately with the therapist. Dyads will be assessed at pre-, post-, and 3-months post-treatment. Study outcomes will be weight, symptoms (i.e., pain, fatigue, distress), eating behavior, and physical activity. Exploratory outcomes examine biomarkers (e.g., insulin, pro-inflammatory cytokines) associated with health outcomes for cancer survivors and their partners. The results of this study will provide preliminary data about the value of a dyadic intervention to decrease weight, improve diet, and increase physical activity while addressing symptoms that frequently serve as barriers to weight loss/maintenance. These findings will have the direct potential to produce significant public health benefit by impacting weight, a variable that has been consistently linked to poor quality of
life and poor health outcomes.
描述(由适用提供):乳腺癌是女性最常见的癌症,估计表明乳腺癌生存中的三分之一是肥胖的。肥胖的乳腺癌生存的伴侣也可能超重或肥胖。超重或肥胖与疾病进展,复发和乳腺癌生存的死亡风险增加以及伴侣的健康状况不佳有关(例如心血管疾病,免疫学功能受损,死亡率)。对于冲浪者和伴侣,疼痛,疲劳和心理困扰都是常见的。这些症状可以成为健康饮食和体育锻炼的障碍,这是减肥和维持所需的两种行为。研究表明,夫妻内的健康行为之间存在显着和积极的关系。二元健康行为改变干预措施已经表现出效率,甚至比仅针对一个人的干预措施更有效。癌症生存的行为减肥干预措施通常不涉及伴侣。此外,行为减肥干预措施很少解决与不良饮食和不活跃有关的身体和心理症状。我们建议对肥胖乳腺癌存活及其伴侣的新型二元行为体重和症状管理干预的新型二元行为体重和症状管理干预的可行性,可接受性和初始效率。拟议的项目包括两个阶段。第一阶段将包括干预开发和完善。干预开发将由研究团队的先前工作,公共应对和行为改变的相互依赖模型以及从参与焦点小组的二元组获得的信息(n = 3个焦点小组,n = 15个二元组)获得指导。然后,将使用5个二元组对干预方案进行测试,以协助改进干预含量。在第二阶段,将检查干预措施的可行性,可接受性和初始效率。调整治疗后的第一年,肥胖的勇敢癌症的存活及其超重或肥胖伴侣(n = 20个二元组)将每周进行6次和6个每两周一次的课程,总共在大约5个月中分布了12个课程。干预措施将以基于夫妻的格式提供,每个二元组将与治疗师分开相遇。二元组将在治疗前,后和3个月进行评估。研究结果将是体重,症状(即疼痛,疲劳,困扰),饮食行为和体育锻炼。探索性结果考试生物标志物(例如胰岛素,促炎细胞因子)与癌症生存的健康结果及其伴侣有关。这项研究的结果将提供有关减轻体重,改善饮食和增加体育锻炼的二元干预价值的初步数据,同时解决经常作为减肥/维持障碍的症状。这些发现将具有直接潜力,可以通过影响体重来产生重大的公共卫生益处,这一变量一直与质量差的差异有关
生活和健康状况不佳。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
DEVELOPMENT, FEASIBILITY, AND ACCEPTABILITY OF A BEHAVIORAL WEIGHT AND SYMPTOM MANAGEMENT INTERVENTION FOR BREAST CANCER SURVIVORS AND INTIMATE PARTNERS.
- DOI:10.48252/jcr57
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Dorfman CS;Somers TJ;Shelby RA;Winger JG;Patel ML;Kimmick G;Craighead L;Keefe FJ
- 通讯作者:Keefe FJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Caroline Dorfman其他文献
Caroline Dorfman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Caroline Dorfman', 18)}}的其他基金
Improving Symptom Management for Adolescents and Young Adults with Advanced Cancer: Development and Pilot Testing of a Novel Intervention
改善晚期癌症青少年和年轻人的症状管理:新型干预措施的开发和试点测试
- 批准号:
10527066 - 财政年份:2022
- 资助金额:
$ 0.07万 - 项目类别:
Improving Symptom Management for Survivors of Young Adult Cancer
改善年轻成人癌症幸存者的症状管理
- 批准号:
10474989 - 财政年份:2019
- 资助金额:
$ 0.07万 - 项目类别:
Improving Symptom Management for Survivors of Young Adult Cancer
改善年轻成人癌症幸存者的症状管理
- 批准号:
10016233 - 财政年份:2019
- 资助金额:
$ 0.07万 - 项目类别:
Improving Symptom Management for Survivors of Young Adult Cancer
改善年轻成人癌症幸存者的症状管理
- 批准号:
10219205 - 财政年份:2019
- 资助金额:
$ 0.07万 - 项目类别:
Improving Symptom Management for Survivors of Young Adult Cancer
改善年轻成人癌症幸存者的症状管理
- 批准号:
10684000 - 财政年份:2019
- 资助金额:
$ 0.07万 - 项目类别:
Behavioral Weight and Symptom Management for Breast Cancer Survivors and Partners
乳腺癌幸存者和伴侣的行为体重和症状管理
- 批准号:
8983272 - 财政年份:2015
- 资助金额:
$ 0.07万 - 项目类别:
相似国自然基金
穿透性靶向胰腺癌内cDC1的纳米佐剂调控溶酶体逃逸促进放疗诱导ICD的机制研究
- 批准号:82303680
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多级改造的工程化外泌体自佐剂疫苗平台实现鼻上皮细胞感染拟态和粘膜递送的研究
- 批准号:32371440
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
展示PD-L1抗体的纳米锰佐剂联合放疗以诱导原位肿瘤疫苗的产生及其机制的探究
- 批准号:32371518
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
靶向FPPS的双磷酸疫苗佐剂的开发
- 批准号:82341040
- 批准年份:2023
- 资助金额:100 万元
- 项目类别:专项基金项目
应用于冠状病毒广谱疫苗开发的新型全链式免疫增强型佐剂研究
- 批准号:82341036
- 批准年份:2023
- 资助金额:110 万元
- 项目类别:专项基金项目
相似海外基金
Sonodynamic therapy using MRI-guided focused ultrasound in combination with 5-aminolevulinic acid to treat recurrent glioblastoma multiforme
使用 MRI 引导聚焦超声联合 5-氨基乙酰丙酸的声动力疗法治疗复发性多形性胶质母细胞瘤
- 批准号:
10699858 - 财政年份:2023
- 资助金额:
$ 0.07万 - 项目类别:
Investigating metabolism and DNA damage repair in uropathogenic Escherichia coli fluoroquinolone persisters
研究泌尿道致病性大肠杆菌氟喹诺酮类持续存在的代谢和 DNA 损伤修复
- 批准号:
10747651 - 财政年份:2023
- 资助金额:
$ 0.07万 - 项目类别:
Characterizing the immune infiltrate in muscle-invasive urothelial carcinoma
肌层浸润性尿路上皮癌免疫浸润的特征
- 批准号:
10738992 - 财政年份:2023
- 资助金额:
$ 0.07万 - 项目类别:
Multidomain Peptide Hydrogels as a Therapeutic Delivery Platform for Cancer Treatment
多域肽水凝胶作为癌症治疗的治疗传递平台
- 批准号:
10743144 - 财政年份:2023
- 资助金额:
$ 0.07万 - 项目类别:
Computational imaging approaches to personalized gastric cancer treatment
个性化胃癌治疗的计算成像方法
- 批准号:
10585301 - 财政年份:2023
- 资助金额:
$ 0.07万 - 项目类别: